Revance Therapeutics, Inc. (RVNC) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	110.6	333.6	171.2	73.3	282.9	63.5	201.6	171.0
Short-term investments	114.4	102.9	119.0	102.6		122.0	50.7
Accounts receivable, net	3.3	1.8		27.0	0.0	0.1	0.1	0.3
Inventories	10.2	5.9
Other current assets	7.5	5.8	6.5	5.1	2.3	7.0	1.6	1.4
Total current assets	246.1	450.0	296.6	207.9	285.2	192.7	254.0	172.7
Property, plant, and equipment, net	24.7	17.5	14.8	14.4	9.3	10.6	19.7	19.3
Intangibles	55.3	71.3
Goodwill	147.0	147.0
Long-term investments							1.8
Other fixed assets	8.7	1.3	1.7	3.2	0.7	0.5		0.0
Total assets	531.2	720.2	340.3	226.3	295.7	204.4	275.8	192.5

Accounts payable	10.6	12.7	8.0	8.4	6.8	3.8	2.7	3.1
Accrued expenses	39.6	32.9	18.6	14.9	12.2	12.4	6.2	4.1
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6
Short-term debt								2.6
Other current liabilities	17.1	15.4	14.3	8.6	1.9	3.5	3.1	0.3
Total current liabilities	67.3	61.0	41.0	32.0	20.9	19.6	12.0	10.2
Long-term debt	280.6	180.5				1.9	5.3	0.6
Other liabilities	114.8	104.4	73.8	48.8	6.0	5.8	5.2	5.3
Total liabilities	462.7	345.9	114.8	80.7	26.9	27.3	22.6	16.1

Shareholders' equity [+]	68.5	374.3	225.5	145.6	268.8	177.1	253.3	176.4
Paid-in capital	1,466.4	1,500.5	1,069.6	830.4	811.0	598.6	585.5	435.1
Retained earnings	-1,398.0	-1,126.3	-844.2	-684.8	-542.2	-421.5	-332.3	258.8
Tangible shareholders' equity	-133.8	156.0	225.5	145.6	268.8	177.1	253.3	176.4